Literature DB >> 9573100

Cloning of Syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis.

P C Melby1, V V Tryon, B Chandrasekar, G L Freeman.   

Abstract

The Syrian golden hamster (Mesocricetus auratus) is uniquely susceptible to a variety of intracellular pathogens and is an excellent model for a number of human infectious diseases. The molecular basis for this high level of susceptibility is unknown, and immunological studies related to this model have been limited by the lack of available reagents. In this report we describe the cloning and sequence analysis of portions of the Syrian hamster interleukin 2 (IL-2), IL-4, gamma interferon (IFN-gamma), tumor necrosis factor alpha, IL-10, IL-12p40, and transforming growth factor beta cDNAs. In addition, we examined the cytokine response to infection with the intracellular protozoan Leishmania donovani in this animal model. Sequence analysis of the hamster cytokines revealed 69 to 93% homology with the corresponding mouse, rat, and human nucleotide sequences and 48 to 100% homology with the deduced amino acid sequences. The hamster IFN-gamma, compared with the mouse and rat homologs, had an additional 17 amino acids at the C terminus that could decrease the biological activity of this molecule and thus contribute to the extreme susceptibility of this animal to intracellular pathogens. The splenic expression of these genes in response to infection with L. donovani, the cause of visceral leishmaniasis (VL), was determined by Northern blotting. VL in the hamster is a progressive, lethal disease which very closely mimics active human disease. In this model there was pronounced expression of the Th1 cytokine mRNAs, with transcripts being detected as early as 1 week postinfection. Basal expression of IL-4 in uninfected hamsters was prominent but did not increase in response to infection with L. donovani. IL-12 transcript expression was detected at low levels in infected animals and paralleled the expression of IFN-gamma. Expression of IL-10, a potent macrophage deactivator, increased throughout the course of infection and could contribute to the progressive nature of this infection. These initial studies are the first to examine the molecular immunopathogenesis of a hamster model of VL infection and indicate that progressive disease in this model of VL is not associated with early polarization of the splenic cellular immune response toward a Th2 phenotype and away from a Th1 phenotype.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573100      PMCID: PMC108174          DOI: 10.1128/IAI.66.5.2135-2142.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  60 in total

1.  Structural requirements for agonist activity of a murine interferon-gamma peptide.

Authors:  B E Szente; I J Weiner; M J Jablonsky; N R Krishna; B A Torres; H M Johnson
Journal:  J Interferon Cytokine Res       Date:  1996-10       Impact factor: 2.607

2.  Molecular mimicry and the generation of host defense protein diversity.

Authors:  P M Murphy
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

3.  Expression of human immune interferon cDNA in E. coli and monkey cells.

Authors:  P W Gray; D W Leung; D Pennica; E Yelverton; R Najarian; C C Simonsen; R Derynck; P J Sherwood; D M Wallace; S L Berger; A D Levinson; D V Goeddel
Journal:  Nature       Date:  1982-02-11       Impact factor: 49.962

4.  Induction of proinflammatory cytokine expression in experimental acute Chagasic cardiomyopathy.

Authors:  B Chandrasekar; P C Melby; D A Troyer; G L Freeman
Journal:  Biochem Biophys Res Commun       Date:  1996-06-14       Impact factor: 3.575

5.  Induction of macrophage killing of Leishmania donovani by human CD4+ T cell clones.

Authors:  P C Melby; G Valencia-Pacheco; F Andrade-Narváez
Journal:  Arch Med Res       Date:  1996       Impact factor: 2.235

6.  Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani.

Authors:  P C Melby; Y Z Yang; J Cheng; W Zhao
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

7.  Hypoxanthine-guanine phosphoribosyltransferase genes of mouse and Chinese hamster: construction and sequence analysis of cDNA recombinants.

Authors:  D S Konecki; J Brennand; J C Fuscoe; C T Caskey; A C Chinault
Journal:  Nucleic Acids Res       Date:  1982-11-11       Impact factor: 16.971

8.  In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma.

Authors:  C L Karp; S H el-Safi; T A Wynn; M M Satti; A M Kordofani; F A Hashim; M Hag-Ali; F A Neva; T B Nutman; D L Sacks
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

9.  Structure and expression of a cloned cDNA for human interleukin-2.

Authors:  T Taniguchi; H Matsui; T Fujita; C Takaoka; N Kashima; R Yoshimoto; J Hamuro
Journal:  Nature       Date:  1983 Mar 24-30       Impact factor: 49.962

10.  Isolation and characterization of a full-length expressible cDNA for human hypoxanthine phosphoribosyl transferase.

Authors:  D J Jolly; H Okayama; P Berg; A C Esty; D Filpula; P Bohlen; G G Johnson; J E Shively; T Hunkapillar; T Friedmann
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

View more
  48 in total

Review 1.  Clinical and experimental advances in treatment of visceral leishmaniasis.

Authors:  H W Murray
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

2.  Setting new immunobiological parameters in the hamster model of visceral leishmaniasis for in vivo testing of antileishmanial compounds.

Authors:  M A Dea-Ayuela; S Rama-Iñiguez; J M Alunda; F Bolás-Fernandez
Journal:  Vet Res Commun       Date:  2007-01-19       Impact factor: 2.459

3.  Proinflammatory and immunomodulatory cytokine mRNA time course profiles in hamsters infected with a virulent variant of Leptospira interrogans.

Authors:  Frédérique Vernel-Pauillac; Fabrice Merien
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

4.  Photodynamic vaccination of hamsters with inducible suicidal mutants of Leishmania amazonensis elicits immunity against visceral leishmaniasis.

Authors:  Shraddha Kumari; Mukesh Samant; Prashant Khare; Pragya Misra; Sujoy Dutta; Bala Krishna Kolli; Sharad Sharma; Kwang Poo Chang; Anuradha Dube
Journal:  Eur J Immunol       Date:  2009-01       Impact factor: 5.532

5.  Designing therapies against experimental visceral leishmaniasis by modulating the membrane fluidity of antigen-presenting cells.

Authors:  Subha Banerjee; June Ghosh; Subha Sen; Rajan Guha; Ranjan Dhar; Moumita Ghosh; Sanchita Datta; Bikramjit Raychaudhury; Kshudiram Naskar; Arun Kumar Haldar; C S Lal; K Pandey; V N R Das; Pradeep Das; Syamal Roy
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

6.  Immunogenicity of the P-8 amastigote antigen in the experimental model of canine visceral leishmaniasis.

Authors:  E Carrillo; S Ahmed; K Goldsmith-Pestana; J Nieto; Y Osorio; B Travi; J Moreno; D McMahon-Pratt
Journal:  Vaccine       Date:  2006-11-10       Impact factor: 3.641

7.  Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis.

Authors:  Anil Kumar Jaiswal; Prashant Khare; Sumit Joshi; Pramod Kumar Kushawaha; Shyam Sundar; Anuradha Dube
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

8.  Duplex real-time reverse transcriptase PCR to determine cytokine mRNA expression in a hamster model of New World cutaneous leishmaniasis.

Authors:  Claudia M Espitia; Weiguo Zhao; Omar Saldarriaga; Yaneth Osorio; Lisa M Harrison; Michael Cappello; Bruno L Travi; Peter C Melby
Journal:  BMC Immunol       Date:  2010-06-22       Impact factor: 3.615

9.  Yellow fever virus infection in Syrian golden hamsters: relationship between cytokine expression and pathologic changes.

Authors:  Guangyu Li; Tao Duan; Xiaoyan Wu; Robert B Tesh; Lynn Soong; Shu-Yuan Xiao
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

10.  Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters.

Authors:  Patrycja Koszałka; Ewa Szmit; Andrzej Myśliwski; Jacek Bigda
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-07-23       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.